Cargando…

Are Hepatic Adenomas Premalignant?

Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cel...

Descripción completa

Detalles Bibliográficos
Autor principal: Nagorney, David M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423828/
https://www.ncbi.nlm.nih.gov/pubmed/9187555
http://dx.doi.org/10.1155/1996/59629
_version_ 1782156190099177472
author Nagorney, David M.
author_facet Nagorney, David M.
author_sort Nagorney, David M.
collection PubMed
description Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cell adenomas over a 30-year period. Interventions: Liver resection and/or tumor biopsy. Main Outcome Measures: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival. Results: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma. Conclusions: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alphafetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period.
format Text
id pubmed-2423828
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-24238282008-07-08 Are Hepatic Adenomas Premalignant? Nagorney, David M. HPB Surg Research Article Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cell adenomas over a 30-year period. Interventions: Liver resection and/or tumor biopsy. Main Outcome Measures: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival. Results: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma. Conclusions: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alphafetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period. Hindawi Publishing Corporation 1996 /pmc/articles/PMC2423828/ /pubmed/9187555 http://dx.doi.org/10.1155/1996/59629 Text en Copyright © 1996 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nagorney, David M.
Are Hepatic Adenomas Premalignant?
title Are Hepatic Adenomas Premalignant?
title_full Are Hepatic Adenomas Premalignant?
title_fullStr Are Hepatic Adenomas Premalignant?
title_full_unstemmed Are Hepatic Adenomas Premalignant?
title_short Are Hepatic Adenomas Premalignant?
title_sort are hepatic adenomas premalignant?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423828/
https://www.ncbi.nlm.nih.gov/pubmed/9187555
http://dx.doi.org/10.1155/1996/59629
work_keys_str_mv AT nagorneydavidm arehepaticadenomaspremalignant